Incyte (INCY) Other financing activities (2011 - 2026)
Incyte (INCY) posted Other financing activities of $97.9 million for Q1 2026, down 38.88% on a QoQ basis from $160.2 million in Q4 2025, and up 2923.31% year-over-year from $3.2 million in Q1 2025.
Incyte (INCY) Other financing activities (2011 - 2026) Analysis & Trends
Incyte's Other financing activities history runs 16 years deep, the most recent figure standing at $97.9 million for Q1 2026.
- Quarterly Other financing activities rose 2923.31% year-over-year to $97.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $316.4 million (up 507.82% YoY) and the FY2025 annual result came in at $221.8 million, up 349.81% from the prior year.
- Other financing activities was $97.9 million for Q1 2026 at Incyte, down from $160.2 million in the prior quarter.
- Across five years, Other financing activities topped out at $160.2 million in Q4 2025 and bottomed at -$48000.0 in Q3 2023.
- A 5-year average of $27.4 million and a median of $14.5 million in 2024 frame the typical range for Other financing activities.
- Annual changes were most pronounced in 2023 — Other financing activities plunged 100.91% — and 2025, when it soared 3287.68%.
- Incyte's Other financing activities stood at $18.1 million in 2022, then slumped by 58.53% to $7.5 million in 2023, then soared by 339.79% to $33.1 million in 2024, then soared by 384.62% to $160.2 million in 2025, then plunged by 38.88% to $97.9 million in 2026.
- Business Quant data shows INCY's Other financing activities at $97.9 million in Q1 2026, $160.2 million in Q4 2025, and $43.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Incyte | 23.33 Bn | 19.32 Bn | 1.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 97.93 Mn |
| Mar 31, 2026 | 97.93 Mn |
| Dec 31, 2025 | 160.21 Mn |
| Dec 31, 2025 | 160.21 Mn |
| Sep 30, 2025 | 43.43 Mn |
| Sep 30, 2025 | 43.43 Mn |
| Jun 30, 2025 | 14.88 Mn |
| Jun 30, 2025 | 14.88 Mn |
| Mar 31, 2025 | 3.24 Mn |
| Mar 31, 2025 | 3.24 Mn |
| Dec 31, 2024 | 33.06 Mn |
| Dec 31, 2024 | 33.06 Mn |
| Sep 30, 2024 | 1.28 Mn |
| Sep 30, 2024 | 1.28 Mn |
| Jun 30, 2024 | 14.48 Mn |
| Jun 30, 2024 | 14.48 Mn |
| Mar 31, 2024 | 477,000.00 |
| Mar 31, 2024 | 477,000.00 |
| Dec 31, 2023 | 7.52 Mn |
| Dec 31, 2023 | 7.52 Mn |